| Literature DB >> 35045855 |
Elham Abdalmaleki1, Zhaleh Abdi1, Sahand Riazi Isfahani1, Sara Safarpoor1, Bahar Haghdoost1,2, Saharnaz Sazgarnejad1,2, Elham Ahmadnezhad3.
Abstract
BACKGROUND: The increasing prevalence of non-communicable diseases (NCDs) has some major implications on many countries to achieve universal health coverage. This study aimed to investigate the implementation of Global School-based Student Health Survey (GSHS), which is used to assess the risk factors of NCDs among children and adolescents in the eastern Mediterranean region (EMR).Entities:
Keywords: Adolescence; Eastern Mediterranean region; Global school-based student health survey; Non-communicable diseases; Sustainable development goals; Universal health coverage
Mesh:
Year: 2022 PMID: 35045855 PMCID: PMC8767753 DOI: 10.1186/s12889-022-12502-8
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Fig. 1PRISMA Flowchart. The PRISMA flow diagram for the review detailing the database searches, the number of abstracts screened, and the full texts retrieved
Surveys’ modules examined in EMR countries Table
| No | Module |
|---|---|
| 36 | Dietary behaviors and overweight |
| 27 | Alcohol and other drug use |
| 37 | Hygiene |
| 32 | Mental health |
| 35 | Physical activity |
| 37 | Protective factors |
| 31 | Tobacco use |
| 35 | Violence and unintentional injury |
| 1 | Sexual behaviours that contribute to HIV infections |
| 1 | Other Sexually transmitted infections (STIs) |
| 1 | Unintended pregnancies |
Characteristics of the included surveys
| Country | Survey’s Name | Implementation Year | Sample Size (Students) | Reponses Rate (%) | |
|---|---|---|---|---|---|
| Jordan | GSHS | 2004 | 2457 | 95.0 | |
| 2007 | 2197 | 99.8 | |||
| Afghanistan | GSHS | 2014 | 2579 | 79.0 | |
| Iran | CASPIAN | 2004 | 21,111 | – | |
| 2007 | 9171 | – | |||
| 2010 | 5570 | – | |||
| 2013 | 13,486 | 90.6 | |||
| 2016 | 14,274 | 99.0 | |||
| United Arab Emirates | GSHS | 2005 | 15,790 | 89.0 | |
| 2010 | 2581 | 91.0 | |||
| 2016 | 5849 | 80.0 | |||
| Bahrain | GSHS | 2016 | 7141 | 89.0 | |
| Pakistan | GSHS | 2009 | 5192 | 76.0 | |
| Tunisia | GSHS | 2008 | 2870 | 83.0 | |
| Djibouti | GSHS | 2007 | 1777 | 83.0 | |
| Sudan | GSHS | 2012 | 2211 | 77.0 | |
| Syrian Arab Republic | GSHS | 2010 | 3102 | 97.0 | |
| Iraq | GSHS | 2012 | 2038 | 88.0 | |
| Saudi Arabia | Jeeluna | 2012 | 12,121 | 62.2 | |
| Oman | GSHS | 2005 | 2979 | 97.0 | |
| 2010 | 1606 | 89.0 | |||
| 2015 | 3468 | 92.0 | |||
| Qatar | GSHS | 2011 | 2021 | 87.0 | |
| Kuwait | GSHS | 2011 | 2672 | 85.0 | |
| 2015 | 3637 | 78.0 | |||
| Palestine | Gaza | GSHS | 2010 | 2677 | 95.0 |
| UNWRAa Gaza | 2122 | 95.0 | |||
UNWRA Lebanon | 2187 | 96.0 | |||
UNWRA Syrian | 2120 | 94.0 | |||
UNWRA West Bank | 2015 | 90.0 | |||
| West Bank | 1908 | 94.0 | |||
| Lebanon | GSHS | 2005 | 5115 | 88.0 | |
| 2011 | 2286 | 87.0 | |||
| 2017 | 5708 | 82.0 | |||
| Libya | GSHS | 2007 | 2242 | 98.0 | |
| Morocco | GSHS | 2006 | 2670 | 84.0 | |
| 2010 | 2924 | 92.0 | |||
| 2016 | 6745 | 91.0 | |||
| Egypt | GSHS | 2006 | 5249 | 87.0 | |
| 2011 | 2568 | 85.0 | |||
| Yemen | GSHS | 2008 | 1175 | 82.0 | |
| 2014 | 2655 | 75.0 | |||
aUnited Nations Relief and Works Agency for Palestine Refugees (UNRWA)
Risk levels of the non-communicable diseases’ risk factors among students aged 13–15 years in EMR counties (percent)
1United Nations Relief and Works Agency for Palestine Refugees (UNRWA)
*T Total, M Male, F Female
Risk levels of the non-communicable diseases’ risk factors among students aged 13–17 years in EMR counties (percent)
*TTotal, M Male, F Female
Result of meta-analysis and heterogeneity on prevalence of overweight, obesity, physical inactivity, tobacco use (any products & cigarettes) by age group (13–15 & 13–17 years old)
| Overall (all EMR countries) | ||||||
|---|---|---|---|---|---|---|
| Age group | Result | Dietary Behaviors | Physical Inactivity | Tobacco Use | ||
| overweight | obese | Any Products | Cigarettes | |||
pooled estimate prevalence (95% CI) | 24.5 (20.6–28.8) | 7.3 (5.4–9.5) | 82.4 (80.7–84.1) | 14.3 (10.53–18.67) | 9.6 (8.1–11.3) | |
| I2 | 99.6 | 99.4 | 98.3 | 99.5 | 98.7 | |
pooled estimate prevalence (95% CI) | 19.8 (13.2–27.3) | 9.7 (6.2–14.0) | 86.1 (84.1–87.9) | 17.8 (11.8–24.7) | 11.5 (9.41–13.89 | |
| I2 | 99.8 | 99.7 | 98.3 | 99.6 | 99.0 | |
| P-value* | ||||||
*p-value for Chi2 statistic for heterogeneity
| 16% or above
| 7–15%
| Below 7%
|
| 70% or above
| 50–69%
| Below 50%
|
| 20% or above
| 10–19%
| Below 10%
|
| 40% or above
| 20–39%
| Below 20%
|